Go Pro

Indaptus Therapeutics (INDP) News Today

Indaptus Therapeutics logo
$1.14 -0.01 (-0.44%)
As of 04:00 PM Eastern

Indaptus Therapeutics Latest News

Indaptus Updates ATM Agreement to Expand Capital Flexibility
Indaptus Therapeutics Appoints David Natan to Board
Why did INDP stock gain 12% today?
Indaptus Therapeutics Provides Clinical Update
Indaptus Therapeutics Announces Reverse Stock Split
Indaptus Therapeutics reports new data on Phase 1 trial of Decoy20
Indaptus Therapeutics reports FY24 EPS ($1.61) vs ($1.83) last year
Indaptus Therapeutics expands patent portfolio in China, Japan, Israel

Indaptus Therapeutics Media Mentions By Week

Indaptus Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INDP
News Sentiment

1.63

0.97

Average
Healthcare
News Sentiment

Indaptus Therapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INDP Articles
This Week

2

1

INDP Articles
Average Week

Indaptus Therapeutics Trends on MarketBeat

This week vs. last week
Searches
4
Page Views
1,879
-4%
Get Indaptus Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for INDP and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Indaptus Therapeutics dated 9/1/2026.
From Our Partners